Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.450
-0.145-2.59%
Volume:92.87M
Turnover:504.61M
Market Cap:101.82B
PE:35.99
High:5.500
Open:5.500
Low:5.380
Close:5.595
52wk High:9.017
52wk Low:4.190
Shares:18.68B
HK Float Shares:18.68B
Volume Ratio:0.98
T/O Rate:0.50%
Dividend:0.12
Dividend Rate:2.24%
EPS(LYR):0.151
ROE:14.07%
ROA:7.51%
PB:2.68
PE(LYR):35.99
PS:2.59

Loading ...

Sino Biopharmaceutical Forms 51:49 JV With Tempo Scan to Accelerate Innovative Drug Access in Indonesia

Bulletin Express
·
Jul 27

Sino Biopharmaceutical - Enters Joint Venture with Tempo Scan to Establish PT Tempo Cttq Biopharmaceutical Indonesia

THOMSON REUTERS
·
Jul 27

Sino Biopharmaceutical - Holds 51% Stake in Joint Venture, Tempo Scan Holds 49%

THOMSON REUTERS
·
Jul 27

Sino Biopharmaceutical - Joint Venture to Focus on Regulatory, Clinical, Commercialization, and Local Manufacturing in Indonesia

THOMSON REUTERS
·
Jul 27

Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$8.26 From HK$8.67, Keeps at Buy

MT Newswires Live
·
Jul 27

Sino Biopharma Unit Gets Trial Approval for Chronic Hepatitis B Drug in China

MT Newswires Live
·
Jul 23

SBP Group obtains NMPA clearance to begin clinical trial of PreS1-targeting IM-101 for chronic hepatitis B

Bulletin Express
·
Jul 23

IM-101 Injection, a PreS1-Targeting Novel Therapy, Receives NMPA Clearance for Clinical Trials in Chronic Hepatitis B

Stock News
·
Jul 23

Sino Biopharm Says China NMPA Clears Im-101 Hepatitis B Drug for Clinical Trial

Reuters
·
Jul 23

Sino Biopharmaceutical - Enters Strategic Collaboration with GSK for Bepirovirsen Launch in China

THOMSON REUTERS
·
Jul 23

Sino Biopharmaceutical - Im-101 Injection Receives Nmpa Clinical Trial Approval for Chronic Hepatitis B

THOMSON REUTERS
·
Jul 23

Sino Biopharmaceutical Stock Slips 3.0% in Hong Kong, Underperforms Competitors

Dow Jones
·
Jul 23

Movement Alert|SBP GROUP Declines 3.18% in Regular Trading, Trading at 5.18 HKD

Market Focus
·
Jul 23

Movement Alert|Sino Biopharmaceutical Rises 3.13% in Regular Trading, Pharma Sector Rebounds as Multiple Recent Catalysts Continue to Ferment

Market Focus
·
Jul 22

Sino Biopharmaceutical Stock Falls 1.2% in Hong Kong, Underperforms Competitors

Dow Jones
·
Jul 21

Movement Alert|Sino Biopharmaceutical Falls 3.09% in Regular Trading, Trading at 5.01 HKD

Market Focus
·
Jul 21

Sino Biopharmaceutical Stock Advances 3.8% in Hong Kong

Dow Jones
·
Jul 20

Movement Alert|Sino Biopharmaceutical Rises 3.01% in Regular Trading, Pharmaceutical Sector Rebounds Amid Multiple Pipeline Catalysts

Market Focus
·
Jul 20

Sino Biopharmaceutical Stock Slips 5.3% in Hong Kong

Dow Jones
·
Jul 17

Movement Alert|Sino Biopharmaceutical Falls 3.04% in Regular Trading, Pharmaceutical Sector Broadly Under Pressure

Market Focus
·
Jul 17